VistaGen Therapeutics (VTGN) Earnings Date, Estimates & Call Transcripts $0.60 -0.03 (-4.70%) Closing price 05/18/2026 04:00 PM EasternExtended Trading$0.61 +0.01 (+2.10%) As of 07:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VistaGen Therapeutics Earnings Summary VistaGen Therapeutics announced Q3 2026 earnings on February 12, 2026, reporting an EPS of -$0.45, which topped analysts' consensus estimates of -$0.51 by $0.06. Quarterly revenue was reported to be $0.30 million, above the consensus estimate of $0.14 million. With a trailing EPS of -$1.89, VistaGen Therapeutics' earnings are expected to grow next year, from ($1.88) to ($1.31) per share. Upcoming Q4 Earnings DateJun. 16After Market ClosesEstimatedConsensus EPS (Feb. 12) -$0.51 Actual EPS (Feb. 12) -$0.45 Beat By $0.06 Actual Revenue (Feb. 12) $0.30MQ3 2026 Earnings ResourcesQ3 2026 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)VTGN Upcoming EarningsVistaGen Therapeutics' Q4 2026 earnings is estimated for Tuesday, June 16, 2026, based on past reporting schedules, with a conference call scheduled on Thursday, June 11, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get VistaGen Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on VistaGen Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataVTGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VTGN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. VistaGen Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20261-$0.44-$0.44-$0.44Q2 20261-$0.47-$0.47-$0.47Q3 20261-$0.24-$0.24-$0.24Q4 20261-$0.25-$0.25-$0.25 FY 2026 4 -$1.40 -$1.40 -$1.40 Q1 20271-$0.37-$0.37-$0.37Q2 20271-$0.43-$0.43-$0.43Q3 20271-$0.48-$0.48-$0.48Q4 20271-$0.41-$0.41-$0.41 VistaGen Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 6/16/2026(Estimated)--------2/12/2026Q3 2026-$0.51-$0.45+$0.06-$0.45$0.14M$0.30M11/13/2025Q2 2026-$0.51-$0.54 -$0.03-$0.54$0.16M$0.26M8/7/2025Q1 2026-$0.47-$0.47--$0.47$0.22M$0.24M6/17/2025Q4 2025-$0.52-$0.43+$0.09-$0.43$0.18M-$0.01M2/13/2025Q3 2025-$0.48-$0.46+$0.02-$0.46$0.18M$230.00B11/7/2024Q2 2025-$0.40-$0.42 -$0.02-$0.42$0.34M$0.18M8/13/2024Q1 2025-$0.41-$0.35+$0.06-$0.35$0.30M$0.08M6/11/2024Q4 2024-$0.34-$0.25+$0.09-$0.25$0.41M$0.20M Data powered by Fiscal.ai. VistaGen Therapeutics Earnings - Frequently Asked Questions When is VistaGen Therapeutics' earnings date? VistaGen Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, June 16th, 2026 based off last year's report dates. Learn more on VTGN's earnings history. Did VistaGen Therapeutics beat their earnings estimates last quarter? In the previous quarter, VistaGen Therapeutics (NASDAQ:VTGN) reported ($0.45) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.51) by $0.06. Learn more on analysts' earnings estimate vs. VTGN's actual earnings. How can I listen to VistaGen Therapeutics' earnings conference call? The conference call for VistaGen Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read VistaGen Therapeutics' conference call transcript? The conference call transcript for VistaGen Therapeutics' latest earnings report can be read online. Read Transcript How much revenue does VistaGen Therapeutics generate each year? VistaGen Therapeutics (NASDAQ:VTGN) has a recorded annual revenue of $490,000.00. How much profit does VistaGen Therapeutics generate each year? VistaGen Therapeutics (NASDAQ:VTGN) has a recorded net income of -$51.42 million. VTGN has generated -$1.89 earnings per share over the last four quarters. What is VistaGen Therapeutics' EPS forecast for next year? VistaGen Therapeutics' earnings are expected to grow from ($1.88) per share to ($1.31) per share in the next year. More Earnings Resources from MarketBeat Related Companies Coya Therapeutics Earnings Date Athira Pharma Earnings Date Forum Markets Earnings Date aTyr Pharma Earnings Date Upexi Earnings Date Q32 Bio Earnings Date FitLife Brands Earnings Date Promis Neurosciences Earnings Date Flag Ship Acquisition Earnings Date biote Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Dillard’s Posted a Huge Earnings Beat—So Why Did the Rally Fade?Why Applied Optoelectronics Stock May Be Near a Turning PointIs Everspin Technologies the Next AI Edge Breakout?Peloton Stock Gives Back Gains After Upbeat Earnings ReportDatavault Gains Traction: 5 Reasons to Sell NowTMC Stock: Why This Pre-Revenue Miner Is Worth WatchingRobinhood, SoFi, and Webull Are Telling Very Different Stories This page (NASDAQ:VTGN) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredIs the SpaceX IPO “Rigged?”The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VistaGen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VistaGen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
